Innoviva grants RSUs and options to CAO
Innoviva, Inc. reported that Chief Accounting Officer Marianne Zhen acquired equity awards as compensation.
Rhea-AI Filing Summary
Innoviva, Inc. reported that Chief Accounting Officer Marianne Zhen acquired equity awards as compensation. She was conditionally granted 12,766 time-vested restricted stock units and 31,500 non-statutory stock options with an exercise price of $22.99 per share, each for Innoviva common stock.
The awards are subject to stockholder approval of Innoviva's 2026 Equity Incentive Plan at the 2026 annual meeting on May 4, 2026. Twenty-five percent of both the RSUs and options vest on February 20, 2027, with the remainder vesting in twelve equal quarterly installments, subject to continued service and certain change-in-control and involuntary termination provisions. Following the grant, Zhen directly holds 58,643 common shares and 31,500 options.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 44,266 shares
Grant/Award
2 txns
Insider
Zhen Marianne
Role
Chief Accounting Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Non-statutory Stock Option | 31,500 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 12,766 | $0.00 | $0.00 |
Holdings After Transaction:
Non-statutory Stock Option — 31,500 contracts (Direct);
Common Stock — 58,643 shares (Direct)
Footnotes (2)
- F1. The Reporting Person was conditionally granted time-vested restricted stock units ("RSUs") and non-statutory stock options ("Options"). The RSUs and Options were granted subject to stockholder approval of the Issuer's 2026 Equity Incentive Plan at the Issuer's 2026 annual meeting of stockholders on May 4, 2026, as disclosed in the Issuer's Schedule 14A filed with the Securities and Exchange Commission ("SEC") on March 24, 2026.
- F2. Twenty-five percent of each of the RSUs and Options vest on February 20, 2027 and the balance will vest in twelve (12) substantially equal installments thereafter on each three (3) month anniversary of the initial vesting date, in each case, provided the Reporting Person has provided continuous service to the Issuer through the applicable vesting date, with accelerated vesting (i) with respect to the Options, in the event of a "change in control" (as defined in the Issuer's 2026 Equity Incentive Plan) in which the options are not assumed or replaced, provided that the Reporting Person has not experienced a termination prior to such "change in control," or (ii) with respect to the Options and the RSUs, in the event that the Reporting Person experiences an "involuntary termination" of employment within 24 months following a "change in control" where such awards are assumed or substituted, subject to an effective release of claims.
Key Figures
RSUs granted: 12,766 units
Options granted: 31,500 options
Option exercise price: $22.99 per share
+4 more
7 metrics
RSUs granted
12,766 units
Time-vested RSUs granted to Chief Accounting Officer on May 4, 2026
Options granted
31,500 options
Non-statutory stock options granted on May 4, 2026
Option exercise price
$22.99 per share
Exercise price for Innoviva common stock underlying options
Common shares after grant
58,643 shares
Direct Innoviva common stock holdings following RSU grant
Options outstanding after grant
31,500 options
Total non-statutory stock options held after transaction
Initial vesting date
February 20, 2027
25% of RSUs and options vest on this date
Option expiration
May 3, 2036
Expiration date for non-statutory stock options
Key Terms
restricted stock units, non-statutory stock options, 2026 Equity Incentive Plan, change in control, +1 more
5 terms
restricted stock units financial
"The Reporting Person was conditionally granted time-vested restricted stock units ("RSUs")"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
non-statutory stock options financial
"and non-statutory stock options ("Options"). The RSUs and Options were granted"
Non-statutory stock options are a type of reward that companies give to employees, allowing them to buy company shares at a set price within a certain period. Unlike formal or government-approved plans, these options are more flexible but may have different tax implications. For investors, they can influence a company's stock price and financial health, making them an important factor to consider.
2026 Equity Incentive Plan financial
"subject to stockholder approval of the Issuer's 2026 Equity Incentive Plan at the Issuer's 2026 annual meeting"
change in control financial
"in the event of a "change in control" (as defined in the Issuer's 2026 Equity Incentive Plan)"
A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.
involuntary termination financial
"in the event that the Reporting Person experiences an "involuntary termination" of employment within 24 months"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did Innoviva (INVA) grant to Chief Accounting Officer Marianne Zhen?
Innoviva granted Marianne Zhen 12,766 time-vested restricted stock units and 31,500 non-statutory stock options. Each option covers Innoviva common stock at a $22.99 exercise price, reflecting a compensation-related equity award rather than an open-market stock purchase or sale.
How do the new Innoviva (INVA) RSUs and options for Marianne Zhen vest?
Twenty-five percent of both the RSUs and options vest on February 20, 2027. The remaining portions vest in twelve substantially equal installments every three months thereafter, assuming continuous service, creating a multi‑year retention and incentive structure for the Chief Accounting Officer.
Are Marianne Zhen’s new Innoviva (INVA) equity awards subject to stockholder approval?
Yes. The RSUs and non-statutory stock options were conditionally granted, subject to stockholder approval of Innoviva’s 2026 Equity Incentive Plan at the 2026 annual stockholders’ meeting on May 4, 2026, as described in the company’s Schedule 14A proxy filing.
What are the change-in-control protections on Innoviva (INVA) options and RSUs granted to Marianne Zhen?
The options may accelerate if a change in control occurs and they are not assumed or replaced, provided no prior termination. Both options and RSUs can accelerate if she has an involuntary termination within 24 months after a change in control where awards are assumed or substituted, subject to a release of claims.
What are Marianne Zhen’s Innoviva (INVA) holdings after the reported Form 4 transactions?
After these conditional grants, Marianne Zhen directly holds 58,643 shares of Innoviva common stock and 31,500 non-statutory stock options. These holdings reflect reported positions in this filing and highlight a mix of current ownership and future equity incentives tied to vesting conditions.
AI-generated analysis. How Rhea-AI works. Not financial advice.
